Meeting
2022 ASCO Annual Meeting
Multiparametric analysis in GBM plasma extracellular vesicles (Evs) and surface marker expression profile.
Authors
Abudumijiti(Zack) Aibaidula
Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN
Abudumijiti(Zack) Aibaidula , Cori E. Fain , Luz Cumba Garcia , Miyeon Jung , Aaron J. Johnson , Ian F. Parney
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Primary CNS Tumors–Glioma
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 2038)
DOI
10.1200/JCO.2022.40.16_suppl.2038
Abstract #
2038
Poster Bd #
376
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Molecular characterization of small extracellular vesicles in patients with pancreatic cancer treated with neoadjuvant chemotherapy followed by stereotactic body radiation (SBRT).
First Author: Ravi Kumar Paluri
Poster
2013 ASCO Annual Meeting
Characterization of glioblastoma (GBM) vasculature and protein expression of surrounding tumor cells on single FFPE sections with a multicycle multiplexed in situ immunofluorescent staining technology.
First Author: Jingyu Zhang
Poster
2024 ASCO Annual Meeting
Zotiraciclib for newly diagnosed or recurrent glioblastoma: Updated outcome and biomarker analysis.
First Author: Michael Weller
Poster
2024 ASCO Annual Meeting
Evaluation of a novel extracellular vesicle (EV) based ovarian cancer (OC) screening test in asymptomatic postmenopausal women.
First Author: Brendan Manning